Innovatie

Deep Breath 🫁

Opschaling

Deep Breath is a clinical decision-support system for intensive care with a focus on mechanical lung ventilation

Medisch technologische innovaties

Regio Zuid-Holland

Help ons versnellen

Connect with hospitals, intensivists, reimbursement organizations

Daria Kozlova

https://www.deepbreath.tech/

Probleemstelling

Untimely or incorrect interventions in intensive care

Oplossing

Clinical decision-support system using AI-based algorithm

VWS-missies

Digital and hybrid care solutions to reduce the strain on healthcare professionals. Deep Breath's focuses on improving ICU outcomes and ventilator management with AI, and supports the goal of reducing the need for intensive in-hospital care and improving remote monitoring and care, making patient care more efficient and accessible

Doelgroep

There are about 10,000-12,000 board-certified intensivists in the US. Critical care is highly specialized, and intensivists mainly work in large hospitals and academic medical centers with ICUs.

Europe is more fragmented, but based on ICU capacity and healthcare structures, there are an estimated 25,000-30,000 intensivists across the continent.
Larger countries such as Germany, the UK, and France have the highest numbers, with each having roughly 4,000 to 5,000 intensivists.
In smaller countries like the Netherlands, Switzerland, and Scandinavian nations, the numbers are lower, ranging from 500 to 1,500 intensivists.

Verlaging zorgkosten

Deep Breath contributes to shortening the length of stay and improving patient outcomes

Verdienmodel

It is a SaaS model, the cost is expected to be 500 eur bed/month

Geïnvesteerd vermogen

€ 100 duizend-1miljoen

Concurrentie

Currently, the decision-making is done manually by clinicians at the bedside, intensive care specialist has 10-15 minutes a day on average for 1 patient to analyze the present state, which in many cases is not enough given the fact that there is no trend analysis available.

Ventilator manufacturers make attempts to come up with the same solution however, it will take them 5-10 years to bring it to market in case they are a success

Unieke kenmerken

Fast and accurate detection of possible adverse events during the ventilation in the intensive care using AI-based algorithm pre-trained on thousands of breath curves, trend data analysis

Intellectueel eigendom

All rights belong to Deep Breath B.V. registered in Rotterdam

Organisatie

For now Deep Breath team consists of 6 full-time members as well as clinical advisers from Dutch hospitals

Beschrijving pilotfase

Deep breath is currently tested in Erasmus MC as a part of 4-year RnD project supported by Health Holland and Erasmus MC. The algorithm will be implemented in day-to-day practice of clinicians

Research module is being tested by the partners from Amsterdam UMC

It is used for data collection in one of the biggest IC units in Czech Republic and will be installed for the same purpose in Slovakian hospital in 2 weeks

Betrokken partners

Erasmus MC
Amsterdam UMC
Catharina Hospital Eindhoven
Decin Clinic, Czechia
Kosice Clinic, Slovakia

Aantal gebruikers pilot

0-10

Onderzoeksresultaten

Studies are on-going

Implementatiestrategie

with the help of medical device distributors as well as reimbursement organizations

Reeds in gebruik

The research module is being used in 3 hospitals at the moment

Behaalde prestaties of gewonnen awards

1 mln eur project for RnD supported by Health Holland
pre-seed investment round closed
one of 5 most innovative startups at IntelliHealth, Basel 2022

Productontwikkeling

We plan to add additional sources of data to enable a more accurate monitoring

Internationale ambitie

Deep Breath is exploring pilot project possibilities with German clinics as well as the US

Omzet

€ 11-100k